
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9262146
[patent_doc_number] => 20130344075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 13/153692
[patent_app_country] => US
[patent_app_date] => 2011-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15675
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153692
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/153692 | Polypeptide compounds for inhibiting angiogenesis and tumor growth | Jun 5, 2011 | Issued |
Array
(
[id] => 8842203
[patent_doc_number] => 20130137831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'OPTIMIZED DRUG CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 13/697437
[patent_app_country] => US
[patent_app_date] => 2011-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17336
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697437
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/697437 | OPTIMIZED DRUG CONJUGATES | May 24, 2011 | Abandoned |
Array
(
[id] => 6089045
[patent_doc_number] => 20110217709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'DETECTION OF CHROMSOMAL REGION COPY NUMBER CHANGES TO DIAGNOSE MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 13/110853
[patent_app_country] => US
[patent_app_date] => 2011-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14995
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217709.pdf
[firstpage_image] =>[orig_patent_app_number] => 13110853
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/110853 | DETECTION OF CHROMSOMAL REGION COPY NUMBER CHANGES TO DIAGNOSE MELANOMA | May 17, 2011 | Abandoned |
Array
(
[id] => 8042249
[patent_doc_number] => 20120070849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR RISK STRATIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/098902
[patent_app_country] => US
[patent_app_date] => 2011-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 42117
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20120070849.pdf
[firstpage_image] =>[orig_patent_app_number] => 13098902
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/098902 | METHODS AND COMPOSITIONS FOR RISK STRATIFICATION | May 1, 2011 | Abandoned |
Array
(
[id] => 8815298
[patent_doc_number] => 20130116343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-09
[patent_title] => 'Salivary Protein Markers for Detection of Breast Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/642587
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 25249
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/642587 | Salivary Protein Markers for Detection of Breast Cancer | Apr 20, 2011 | Abandoned |
Array
(
[id] => 8940440
[patent_doc_number] => 20130190237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/639590
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 33562
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13639590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/639590 | METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER | Apr 5, 2011 | Abandoned |
Array
(
[id] => 8346750
[patent_doc_number] => 20120207671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/501600
[patent_app_country] => US
[patent_app_date] => 2011-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 31279
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501600 | COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS | Apr 4, 2011 | Abandoned |
Array
(
[id] => 5959479
[patent_doc_number] => 20110183866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/077380
[patent_app_country] => US
[patent_app_date] => 2011-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 100815
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183866.pdf
[firstpage_image] =>[orig_patent_app_number] => 13077380
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/077380 | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER | Mar 30, 2011 | Abandoned |
Array
(
[id] => 8744861
[patent_doc_number] => 20130084578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'BREAST CANCER RELATED GENE ZNFN3A1'
[patent_app_type] => utility
[patent_app_number] => 13/076137
[patent_app_country] => US
[patent_app_date] => 2011-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15553
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13076137
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/076137 | BREAST CANCER RELATED GENE ZNFN3A1 | Mar 29, 2011 | Abandoned |
Array
(
[id] => 8732685
[patent_doc_number] => 20130078255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'SERUM AND TISSUE BIOMARKERS OF HUMAN HCC'
[patent_app_type] => utility
[patent_app_number] => 13/637751
[patent_app_country] => US
[patent_app_date] => 2011-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13888
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637751
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/637751 | SERUM AND TISSUE BIOMARKERS OF HUMAN HCC | Mar 28, 2011 | Abandoned |
Array
(
[id] => 8585697
[patent_doc_number] => 20130004519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'SMOCI, TENASCIN-C AND BRAIN CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/582268
[patent_app_country] => US
[patent_app_date] => 2011-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20790
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582268
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/582268 | SMOCI, TENASCIN-C AND BRAIN CANCERS | Mar 3, 2011 | Abandoned |
Array
(
[id] => 9197654
[patent_doc_number] => 20130336969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'USE OF OLFACTOMEDIN-4 PROTEIN (OLFM4) IN COLORECTAL CANCER DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/002225
[patent_app_country] => US
[patent_app_date] => 2011-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12620
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002225
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002225 | Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis | Mar 1, 2011 | Issued |
Array
(
[id] => 10091284
[patent_doc_number] => 09128101
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Biomarkers for theranostics'
[patent_app_type] => utility
[patent_app_number] => 13/581795
[patent_app_country] => US
[patent_app_date] => 2011-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 195
[patent_figures_cnt] => 195
[patent_no_of_words] => 143911
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581795
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/581795 | Biomarkers for theranostics | Feb 28, 2011 | Issued |
Array
(
[id] => 9388822
[patent_doc_number] => 08685416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Compositions and methods for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 13/581999
[patent_app_country] => US
[patent_app_date] => 2011-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 23
[patent_no_of_words] => 22098
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581999
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/581999 | Compositions and methods for the treatment of cancer | Feb 28, 2011 | Issued |
Array
(
[id] => 6177252
[patent_doc_number] => 20110177971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR'
[patent_app_type] => utility
[patent_app_number] => 13/024845
[patent_app_country] => US
[patent_app_date] => 2011-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22415
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20110177971.pdf
[firstpage_image] =>[orig_patent_app_number] => 13024845
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/024845 | METHOD FOR DIAGNOSING THE STAGE OF A THYROID TUMOR | Feb 9, 2011 | Abandoned |
Array
(
[id] => 8442262
[patent_doc_number] => 20120258877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/024272
[patent_app_country] => US
[patent_app_date] => 2011-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 29381
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13024272
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/024272 | IDENTIFICATION OF CANCER BIOMARKERS AND PHOSPHORYLATED PROTEINS | Feb 8, 2011 | Abandoned |
Array
(
[id] => 6063004
[patent_doc_number] => 20110200998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'Prognosis and Therapy Predictive Markers and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/023331
[patent_app_country] => US
[patent_app_date] => 2011-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10856
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20110200998.pdf
[firstpage_image] =>[orig_patent_app_number] => 13023331
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/023331 | Prognosis and Therapy Predictive Markers and Methods of Use | Feb 7, 2011 | Abandoned |
Array
(
[id] => 8696854
[patent_doc_number] => 20130058863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => '4-Protein Biomarker Panel for the Diagnosis of Lymphoma from Biospecimen'
[patent_app_type] => utility
[patent_app_number] => 13/576877
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 22010
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13576877
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/576877 | 4-Protein Biomarker Panel for the Diagnosis of Lymphoma from Biospecimen | Feb 3, 2011 | Abandoned |
Array
(
[id] => 6142010
[patent_doc_number] => 20110129416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/012706
[patent_app_country] => US
[patent_app_date] => 2011-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 28069
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129416.pdf
[firstpage_image] =>[orig_patent_app_number] => 13012706
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/012706 | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers | Jan 23, 2011 | Issued |
Array
(
[id] => 8184230
[patent_doc_number] => 20120114670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/011901
[patent_app_country] => US
[patent_app_date] => 2011-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 76259
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114670.pdf
[firstpage_image] =>[orig_patent_app_number] => 13011901
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/011901 | METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS | Jan 22, 2011 | Abandoned |